Agilent Technologies introduced the InfinityLab Pro iQ Series, a new generation of liquid chromatography-mass spectrometry platforms designed for pharmaceutical, biopharmaceutical, and environmental applications. Featuring precision, sensitivity, and intelligent automation, these systems enhance analysis of small molecules, peptides, oligonucleotides, and proteins. The series supports mass confirmation, impurity profiling, biomolecule characterization, and purification workflows, aiming to expand laboratory capabilities and accelerate scientific discovery across diverse sectors.